-
Verily, Samsung Collaborate, Improving AI Trustworthiness, FDA Approval for PathAI
Bio-IT World | Verily Life Sciences and Samsung Electronics America announce a collaboration; Research Solutions launches Scite MCP; PathAI announces Breakthrough Device Designation to PathAssist Derm; and more.
Mar 24, 2026
-
PerturbAI Launches with CRISPR Atlas
Bio-IT World | PerturbAI unveiled the world’s largest in vivo CRISPR atlas this week as it emerged from stealth. The 8 million-cell, brain-wide dataset represents the largest known causal genomics resource generated directly in living tissue.
Mar 20, 2026
-
piRNAs Emerge as a New Frontier in Longevity
Bio-IT World | A new class of molecular biomarkers—piwi-interacting RNAs, or piRNAs—is emerging as researchers explore their potential not just to predict survival, but to actively modulate aging itself. In a study published in Aging Cell, a panel of five circulating piRNAs, combined with high-density lipoprotein particle counts and functional health metrics, demonstrated striking predictive power for short-term survival in older adults.
Mar 19, 2026
-
Open Source ‘Floats All Boats’ in AI-Driven Drug Discovery
Bio-IT World | More than two dozen “grand challenges” remain in small-molecule drug discovery, spanning everything from target selection to developing a medicine that can be safely used in the clinic. No single company can solve all these problems alone, which underscores the importance of computational tools, many of which are built on open-source software.
Mar 17, 2026
-
Ancient Mushroom, Modern Medicine: Paul Stamets Says Agarikon Mycelium May Be Key to Fighting Viral Pandemics
Bio-IT World | Paul Stamets has spent more than four decades in the forests of the Pacific Northwest, carefully prying tissue samples from the undersides of some of the world’s rarest mushrooms. On the stage of February’s Integrative Health Symposium, that lifetime of fieldwork converged with randomized clinical trials and Department of Defense contracts—a collision of ancient ethnobotany and 21st-century immunology that left the audience energized.
Mar 12, 2026


